Equillium

IPO

About

Clinical-stage biotechnology company developing novel therapeutics for severe autoimmune and inflammatory diseases.

BridgeBio Pharma is a clinical-stage biopharmaceutical company developing therapies for genetic d...

Clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for IgG-mediated aut...

Commercial-stage oncology company pioneering antibody drug conjugate therapies for cancer treatment.

Biopharmaceutical oncology company focused on discovery, development, and commercialization of ca...

Global clinical-stage biopharmaceutical company pursuing novel drug development platforms for rar...

Research-based development stage biopharmaceutical company that discovers and develops innovative...